Inventor · disambiguated record
Per-Olof Berggren
Also filed as: BERGGREN PER-OLOF
32 granted patents·20 pending applications·96 citations·filing 2000–2022
96Inventor score
Top patents by PatentIndex Score
52 records- 0194US8030288B2Methods for identifying compounds for the treatment of type 1 diabetesBIOCRINE AB·Filed 2008·Granted Oct 4, 2011·21 cites·6 claims
- 0293US8084439B2Methods for identifying compounds for the treatment of type 1 diabetesBERGGREN PER-OLOF·Filed 2010·Granted Dec 27, 2011·16 cites·12 claims
- 0391US8716241B2ApoIII and the treatment and diagnosis of diabetesBIOCRINE AB·Filed 2013·Granted May 6, 2014·11 cites·4 claims
- 0491US8507444B2ApoIII and the treatment and diagnosis of diabetesBERGGREN PER-OLOF·Filed 2011·Granted Aug 13, 2013·11 cites·4 claims
- 0586US10338060B2Methods for monitoring physiological status of a body organBIOCRINE AB·Filed 2018·Granted Jul 2, 2019·1 cites·21 claims
- 0686US9744232B2Methods for treating and/or limiting development of diabetesBIOCRINE AB·Filed 2016·Granted Aug 29, 2017·2 cites·21 claims
- 0786US8557513B2Methods for treating and/or limiting development of diabetesBERGGREN PER-OLOF·Filed 2012·Granted Oct 15, 2013·4 cites·10 claims
- 0885US9353183B2Methods for treating and/or limiting development of diabetesBIOCRINE AB·Filed 2015·Granted May 31, 2016·2 cites·18 claims
- 0985US9169484B2ApoIII and the treatment and diagnosis of diabetesBIOCRINE AB·Filed 2014·Granted Oct 27, 2015·4 cites·9 claims
- 1079US10060935B2ApoIII and the treatment and diagnosis of diabetesBIOCRINE AB·Filed 2017·Granted Aug 28, 2018·1 cites·5 claims
- 1179US9463205B2Non-invasive in vivo imaging and methods for treating type I diabetesBIOCRINE AB·Filed 2014·Granted Oct 11, 2016·3 cites·6 claims
- 1279US9068973B2Methods for treating and/or limiting development of diabetesBIOCRINE AB·Filed 2013·Granted Jun 30, 2015·2 cites·10 claims
- 1376US11519902B2Methods for monitoring physiological status of a body organBIOCRINE AB·Filed 2019·Granted Dec 6, 2022·0 cites·19 claims
- 1476US10228364B2Methods for monitoring physiological status of a body organBIOCRINE AB·Filed 2017·Granted Mar 12, 2019·1 cites·14 claims
- 1575US2020300875A1ApoCIII and the Treatment and Diagnosis of DiabetesBIOCRINE AB·Filed 2020·Application pending·0 cites
- 1674US9462973B2Methods for monitoring physiological status of a body organBIOCRINE AB·Filed 2013·Granted Oct 11, 2016·4 cites·14 claims
- 1773US10207012B2Non-invasive in vivo imaging and methods for treating type I diabetesBIOCRINE AB·Filed 2016·Granted Feb 19, 2019·1 cites·12 claims
- 1873US9702867B2Methods for monitoring physiological status of a body organBIOCRINE AB·Filed 2016·Granted Jul 11, 2017·1 cites·17 claims
- 1972US9068971B2Methods for treating and/or limiting development of diabetesBIOCRINE AB·Filed 2013·Granted Jun 30, 2015·2 cites·10 claims
- 2071US11707490B2Methods and reagents for treating diabetesBIOCRINE AB·Filed 2019·Granted Jul 25, 2023·0 cites·20 claims
- 2171US10239928B2Method of highly expressing target protein from plant using RbcS fusion protein and method of preparing composition for oral administration of medical protein using target protein expression plant bodyPOSTECH ACAD IND FOUND·Filed 2017·Granted Mar 26, 2019·1 cites·13 claims
- 2271US8466185B2Methods and assays for detecting and treating hypoglycemiaBERGGREN PER-OLOF·Filed 2009·Granted Jun 18, 2013·3 cites·4 claims
- 2371US2023111951A1Methods and reagents for treating diabetesBIOCRINE AB·Filed 2022·Application pending·0 cites
- 2470US9062306B2Methods for identifying compounds for treating type 1 diabetesBERGGREN PER-OLOF·Filed 2004·Granted Jun 23, 2015·2 cites·3 claims
- 2569US10695425B2Methods for treating and/or limiting development of diabetes in subjects with amyotrophic lateral sclerosisBIOCRINE AB·Filed 2018·Granted Jun 30, 2020·0 cites·8 claims
- 2668US2018348240A1ApoCIII and the Treatment and Diagnosis of DiabetesBIOCRINE AB·Filed 2018·Application pending·0 cites
- 2767US10226530B2Methods for treating and/or limiting development of diabetesBIOCRINE AB·Filed 2017·Granted Mar 12, 2019·0 cites·12 claims
- 2865US10493108B2Non-invasive in vivo imaging and methods for treating diabetesBIOCRINE AB·Filed 2018·Granted Dec 3, 2019·0 cites·6 claims
- 2963US2020061121A1Non-invasive in vivo imaging and methods for treating type I diabetesBIOCRINE AB·Filed 2019·Application pending·0 cites
- 3062US2009060843A1Non-Invasive In Vivo Imaging and Methods for Treating Type I DiabetesBIOCRINE AB·Filed 2008·Application pending·0 cites
- 3160US7855049B2Inositol pyrophosphates determine exocytotic capacityBIOCRINE AB·Filed 2008·Granted Dec 21, 2010·0 cites·13 claims
- 3260US2016041191A1ApoIII and the Treatment and Diagnosis of DiabetesBIOCRINE AB·Filed 2015·Application pending·0 cites
- 3359US2015105436A1Methods and Assays for Detecting and Treating HypoglycemiaBIOCRINE AB·Filed 2014·Application pending·0 cites
- 3457US9968675B2Methods for treating and/or limiting development of diabetes in subjects with amyotrophic lateral sclerosisBIOCRINE AB·Filed 2017·Granted May 15, 2018·0 cites·19 claims
- 3556US2015259416A1Methods for treating and/or limiting development of diabetesBIOCRINE AB·Filed 2014·Application pending·0 cites
- 3655US8021853B2Inhibition of the β3 subunit of L-type Ca2+ channelsBIOCRINE AB·Filed 2006·Granted Sep 20, 2011·0 cites·8 claims
- 3754US9700617B2Methods for treating and/or limiting development of diabetes in subjects with amyotrophic lateral sclerosisBIOCRINE AB·Filed 2016·Granted Jul 11, 2017·0 cites·12 claims
- 3854US2017037118A1Methods for treating and/or limiting development of diabetesBIOCRINE AB·Filed 2016·Application pending·0 cites
- 3953US6586188B1Method for identification of compounds that bind to β-tubulin and stimulate insulin secretionBIOVITRUM AB·Filed 2000·Granted Jul 1, 2003·3 cites·21 claims
- 4053US2016069866A1Inhibition of the beta3 subunit of l-type ca2+ channelsBIOCRINE AB·Filed 2015·Application pending·0 cites
- 4152US2014134660A1Inhibition of the beta3 subunit of l-type ca2+ channelsBIOCRINE AB·Filed 2013·Application pending·0 cites
- 4251US7601687B2Mechanism for identifying drugs for the treatment of type II diabetesBIOCRINE AB·Filed 2006·Granted Oct 13, 2009·0 cites·11 claims
- 4351US2013217738A1Methods and Assays for Detecting and Treating HypoglycemiaBERGGREN PER-OLOF·Filed 2013·Application pending·0 cites
- 4450US2011287029A1Inhibition of the beta3 subunit of l-type ca2+ channelsBERGGREN PER-OLOF·Filed 2011·Application pending·0 cites
- 4550US2024207325A1Pancreatic Islets as Protein FactoriesBIOCRINE AB·Filed 2022·Application pending·0 cites
- 4646US2011318325A1Inositol Pyrophosphates Determine Exocytotic CapacityBERGGREN PER-OLOF·Filed 2011·Application pending·0 cites
- 4745US2011092577A1Inositol Pyrophosphates Determine Exocytotic CapacityBIOCRINE AB·Filed 2010·Application pending·0 cites
- 4842US2017035793A1Use of P2X Purinergic Receptor Agonists to Enhance Insulin Secretion In Pancreatic Beta CellsBERGGREN PER-OLOF·Filed 2016·Application pending·0 cites
- 4942US2003180712A1Inhibition of the beta3 subunit of L-type Ca2+ channelsBIOSTRATUM AB·Filed 2003·Application pending·0 cites
- 5042US2013053338A1Use of P2X Purinergic Receptor Agonists to Enhance Insulin Secretion in Pancreatic Beta CellsBERGGREN PER-OLOF·Filed 2011·Application pending·0 cites
Showing the top 50 of 52 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Per-Olof Berggren files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →